headquart san diego california
pure play diabet compani focus continu
reason report
price chang estim chang analysi
increas price outlook look
reiter o/v invest rate increas
price target per share increasingli view
top-lin growth guidanc conserv user base
yield billion run rate impli total user growth
exceed upper-bound annual revenu guidanc posit
momentum build within commerci also medicar
channel intern expans potenti plan dtc initi
signific potenti limit launch prior cye continu
see potenti annual revenu growth prior
inflect behind full scale launch
long-term oper margin target also appear conserv
gener margin expans
year signific leverag still deriv beyond
accordingli reiter o/v rate share
increas price increas former
price target per share follow compani
price target base dcf analysi assum
wacc termin multipl equival
chang estim fine-tun former
billion revenu estim billion increas
former per share ep estim per share
increas former billion estim
billion per share respect figur
billion billion impli annual revenu growth
despit expect million headwind
unfavor mix price likewis annual gross margin guidanc
also reiter addit establish non-
oper adjust ebitda margin target
valuat summari share current trade
averag like multipl figur rel
premium warrant predic upon compani favor
revenu growth margin expans profil larg exist
plan new product cadenc industri leadership
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
oper highlight oper period total revenu million pre-cal consensu
million increas year year figur specif domest sale increas million
total revenu intern sale growth increas million total revenu
dxcm quarterli gross margin increas pre-cal consensu compani report
non- oper margin oper period versu prior year period net
incom million per share includ amort busi transit relat cost
non-cash interest expens adjust mention expens compani report non-gaap
earn per share pre-cal consensu per share
highlight report outstand quarter revenu growth million absolut
year-over-year dollar revenu growth highest gross margin sinc first full year profit
achiev compani goal doubl capac commenc medicar launch
pipelin track conjunct earn call compani reiter previous announc event
stand serv potenti posit catalyst enhanc growth margin profil long-term
includ full roll-out medicar expand access new exist geographi clinic trial
manufactur ramp-up potenti limit launch full commerci launch plan
drive cgm use demonstr valu proposit type non-intens popul doubl capac
fh
balanc sheet review exit oper period billion cash cash equival
billion debt net cash posit million equival net cash per share
revenu essenti in-lin pre-announc
research develop
sell gener administr
deliv signific gm improv due
reduc product cost manufactur autom
oper margin
higher forecast due compani
report sg expens million vs
good sold
incom prior provis incom tax
net incom continu oper
non-gaap ep exclud amort
busi transit relat cost
non-cash interest expens
note million except per share data
compani document stephen inc estim
compani document stephen inc
dollar thousand except per share data
fiscal period
fiscal period
fiscal period
product revenu
develop revenu
revenu
research develop
sell gener administr
research develop
sell gener administr
research develop
compani report stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
